Parvus Therapeutics Inc. is a privately held biopharmaceutical company developing NavacimsTM, a platform technology to treat autoimmune diseases.
Parvus Therapeutics Inc. is seeking a Senior Scientist to join its team and drive projects enabling the translation, validation, and execution of preclinical biomarkers to the clinic. The Senior Scientist will lead context-of-use validation of clinical biomarker assays, write internal SOPs and reports, and participate in lab operation, training, and compliance.
Parvus Therapeutics Inc. is a privately held biopharmaceutical company developing NavacimsTM, a platform technology to treat autoimmune diseases.
4D Molecular Therapeutics